Loh Evan
- SEC CIK
- 0001622680
No open-market purchases or sales filed in the past year.
Current role at each company
- PRTK Paratek Pharmaceuticals, Inc.CEOas of Sep 21, 2023
- EIGR Eiger BioPharmaceuticals, Inc.Directoras of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Loh Evan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PRTK Paratek Pharmaceuticals, Inc.
CEO7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 (view filing) | Aug 9 | 1 day | Loh EvanCEO | SSale | −49.0K | $2.20 | −$107.7K | −3.6%1.33M after | |
| Dec 22, 2022 (view filing) | Dec 21 | 1 day | Loh EvanCEO | SSale | −23.5K | $1.99 | −$46.7K | −1.9%1.21M after | |
| Dec 14, 2022 (view filing) | Dec 12-13 | 2 days | Loh EvanCEO | SSale | −99.8K | $1.97 | −$196.3K | −7.8%1.18M after | 2 lots |
| Nov 1, 2022 (view filing) | Oct 28 | 4 days | Loh EvanCEO | SSale | −8.80K | $3.47 | −$30.6K | −0.7%1.28M after | |
| Aug 10, 2022 (view filing) | Aug 9 | 1 day | Loh EvanCEO | SSale | −44.5K | $2.66 | −$118.4K | −3.4%1.26M after | |
| Dec 15, 2021 (view filing) | Dec 13-15 | 2 days | Loh EvanCEO | SSale | −87.1K | $4.32 | −$376.3K | −8.7%913.3K after | 3 lots |
| Aug 18, 2021 (view filing) | Aug 17 | 1 day | Loh EvanCEO | SSale | −33.9K | $5.12 | −$173.7K | −3.3%1.00M after |